{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:38:17Z","timestamp":1760852297244},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/s11926-000-0079-6","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T16:52:28Z","timestamp":1180975948000},"page":"196-200","source":"Crossref","is-referenced-by-count":13,"title":["Macrophagic myofasciitis"],"prefix":"10.1007","volume":"2","author":[{"given":"P.","family":"Cherin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"79_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","volume":"352","author":"R Gherardi","year":"1998","unstructured":"Gherardi R, Coquet M, Ch\u00e9rin P, et al.: Macrophagic myofasciitis: an emerging entity. Lancet 1998, 352:347\u2013352. The authors described the first cases of a new inflammatory myopathy, called macrophagic myofasciitis, recorded with an increasing frequency from 1993 in the main French myopathologic centers. The disease is histologically characterized by centripetal infiltration of epimysium, perimysium, and perifascicular endomysium by sheets of large cells of the monocyte\/macrophage lineage (CD68+, CD1a-, S100-), with a PAS-positive content.","journal-title":"Lancet"},{"key":"79_CR2","first-page":"593","volume":"65","author":"P Ch\u00e8rin","year":"1998","unstructured":"Ch\u00e8rin P, Gherardi RK, et al.: Apparition d\u2019une nouvelle entit\u00e9: la myofasciite \u00e0 macrophages. Rev Rhuem 1998, 65:593\u2013595.","journal-title":"Rev Rhuem"},{"key":"79_CR3","first-page":"483\u2014489","volume":"20","author":"P Ch\u00e8rin","year":"1999","unstructured":"Ch\u00e8rin P, Laforet P, Gherardi R, et al.: La myofasciite \u00e0 macrophages: description, hypoth\u00e8ses \u00e9tiopathog\u00e8niques. Rev. M\u00e8d. Interne 1999, 20:483\u2014489. The authors discussed the main etiologic hypothesis of the new disease called macrophagic myofasciitis.","journal-title":"Rev. M\u00e8d. Interne"},{"key":"79_CR4","first-page":"1461","volume-title":"Myology","author":"BQ Banker","year":"1993","unstructured":"Banker BQ: Other inflammatory myopathies. In Myology, edn 2, vol 2. Edited by Engel AG, Franzini-Armstrong. New York: McGraw-Hill; 1993:1461\u20131486.","edition":"edn 2"},{"key":"79_CR5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC: Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991, 325:1487\u20131498.","journal-title":"N Engl J Med"},{"key":"79_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199754010-00003","volume":"54","author":"P Ch\u00e9rin","year":"1997","unstructured":"Ch\u00e9rin P: Recognition and management of myositis. Drugs 1997, 54:39\u201349.","journal-title":"Drugs"},{"key":"79_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00005792-199601000-00002","volume":"75","author":"JE Naschitz","year":"1996","unstructured":"Naschitz JE, Boss JH, Misselevitch I, et al.: The fasciitispanniculitis syndromes: clinical and pathologic features. Medicine 1996, 75:6\u201316.","journal-title":"Medicine"},{"key":"79_CR8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/tx00049a003","volume":"8","author":"AN Mayeno","year":"1995","unstructured":"Mayeno AN, Benson LM, Naylor S, et al.: Biotransformation of 3-(phenylamino)1,2-propanediol to 3-(phenylamino) alanine: a chemical link between toxic oil syndrome and eosiniphilia-myalgia syndrome. Chem Res Toxicol 1995, 8: 911\u2013916.","journal-title":"Chem Res Toxicol"},{"key":"79_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0248-8663(96)80718-1","volume":"16","author":"E Hachulla","year":"1995","unstructured":"Hachulla E, Janin A: Les fasciites inflammatoires non infectieuses: un syndrome fronti\u00e8re. Rev M\u00e9d Interne 1995 16:325\u2013335","journal-title":"Rev M\u00e9d Interne"},{"key":"79_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0190-9622(95)90034-9","volume":"33","author":"JL Snow","year":"1995","unstructured":"Snow JL, Daniel Su WP: Histiocytic disorders. J Am Acad Dermatol 1995, 33:111\u2013116.","journal-title":"J Am Acad Dermatol"},{"key":"79_CR11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00005792-199011000-00001","volume":"69","author":"JS Friedlander","year":"1990","unstructured":"Friedlander JS, Weatherall DJ, Ledingham JGG: A chronic granulomatous syndrome of unknown origin. Medicine 1990, 69:325\u2013331.","journal-title":"Medicine"},{"key":"79_CR12","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood.V84.9.2840.2840","volume":"84","author":"MJ Cline","year":"1994","unstructured":"Cline MJ: Histiocytes and histiocytosis. Blood 1994, 84: 2840\u20132853.","journal-title":"Blood"},{"key":"79_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000372-199610000-00008","volume":"18","author":"BWH Zellger","year":"1996","unstructured":"Zellger BWH, Sidoroff A, Orchard G, Cerio R: Non-Langherans cells histiocytosis: a new unifying concept. Am J Dermatopathol 1996, 18:490\u2013504.","journal-title":"Am J Dermatopathol"},{"key":"79_CR14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/gast.1997.v113.pm9247462","volume":"113","author":"T Marth","year":"1997","unstructured":"Marth T, Neurath M, Cuccherini BA, Strober W: Defects of monocyte interleukin 12 production and humoral immunity in Whipple\u2019s disease. Gastroenterology 1997, 113:442\u2013448.","journal-title":"Gastroenterology"},{"key":"79_CR15","first-page":"697","volume":"II","author":"Toxic Epidemic Syndrome Study Group","year":"1981","unstructured":"Toxic Epidemic Syndrome Study Group: Toxic Epidemic Syndrome. Lancet 1981, II:697\u2013702.","journal-title":"Lancet"},{"key":"79_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0049-0172(86)90017-X","volume":"15","author":"A Alonzo-Ruiz","year":"1986","unstructured":"Alonzo-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, et al.: Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986, 15:200\u2013212.","journal-title":"Semin Arthritis Rheum"},{"key":"79_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(90)90421-Z","volume":"335","author":"M Eidson","year":"1990","unstructured":"Eidson M, Philen RM, Sewell CM, et al.: L-tryptophan and eosinophilia-myalgia syndrome in New Mexico. Lancet 1990, 335:645\u2013648.","journal-title":"Lancet"},{"key":"79_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-199007000-00001","volume":"69","author":"LD Kaufman","year":"1990","unstructured":"Kaufman LD, Seidman RJ, Gruber BL: L-tryptophan-associated eosinophilic perimyositis, neuritis and fasciitis: a clinicopathologic and laboratory study of 25 patients. Medicine 1990, 69:187\u2013199.","journal-title":"Medicine"},{"key":"79_CR19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(89)90478-6","volume":"86","author":"E Gertner","year":"1989","unstructured":"Gertner E, Thurn JR, Williams DN, et al.: Zidovudine-associated myopathy. Am J Med 1989, 86:814\u2013818.","journal-title":"Am J Med"},{"key":"79_CR20","first-page":"1647","volume-title":"Pathology of infectious diseases","author":"EE Lack","year":"1997","unstructured":"Lack EE: Malakoplakia. In Pathology of infectious diseases, vol 2. Edited by Connor DH, Chandler FW, Schwartz DA, et al.: Stamford: Appleton and Lange; 1997:1647\u20131654."},{"key":"79_CR21","first-page":"302","volume":"103","author":"D Miranda","year":"1979","unstructured":"Miranda D, Vuletin JC, Kauffman SL: Disseminated histiocytosis and intestinal malakoplakia: occurrence due to Mycobacterium intracellulare infection. Arch Pathol Lab Med 1979, 103:302\u2013305.","journal-title":"Arch Pathol Lab Med"},{"key":"79_CR22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0016-5085(83)80089-4","volume":"85","author":"JS Gillin","year":"1983","unstructured":"Gillin JS, Urmacher C, West R, Shike M: Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple\u2019s disease. Gastroenterology 1983, 85:1187\u20131191.","journal-title":"Gastroenterology"},{"key":"79_CR23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/165.4.702","volume":"165","author":"MB Michelini-Norris","year":"1992","unstructured":"Michelini-Norris MB, Blanchard DK, Pearson CA, Djeu JY: Differential release of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avitulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 1992, 165:702\u2013709.","journal-title":"J Infect Dis"},{"key":"79_CR24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/infdis\/170.2.484","volume":"170","author":"SS Sathe","year":"1994","unstructured":"Sathe SS, Sarai A, Tsigler D, Nedunchezian D: Pentoxifylline aggravates impairment in tumor necrosis factor-alpha secreation and increases mycobacterial load in macrophages from AIDS patients with disseminated Mycobacterium aviumintracellulare complex infection. J Infect Dis 1994, 170:484\u2013487.","journal-title":"J Infect Dis"},{"key":"79_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.157.1.411","volume":"157","author":"DM Frucht","year":"1996","unstructured":"Frucht DM, Holland SM: Defective monocyte costimulation for IFN-g production in familial disseminated Mycobacterium avium-complex infection: abnormal IL-12 regulation. J Immunol 1996, 157:411\u2013416.","journal-title":"J Immunol"},{"key":"79_CR26","first-page":"803","volume":"20","author":"K Sperber","year":"1993","unstructured":"Sperber K, Quraishi H, Kalb TH, et al.: Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1 alpha) and IL-6 in human monocytes and T-cells. J Rheumatol 1993, 20:803\u2013808.","journal-title":"J Rheumatol"},{"key":"79_CR27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gut.18.10.800","volume":"18","author":"M Swash","year":"1977","unstructured":"Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ: Myopathy in Whipples\u2019s disease. Gut1977, 18:800.","journal-title":"Gut"},{"key":"79_CR28","first-page":"897","volume-title":"Pathology of infectious diseases","author":"WO Dobbins III","year":"1997","unstructured":"Dobbins WO III: Whipple\u2019s disease. In Pathology of infectious diseases, vol 1. Edited by Connor DH, Chandler FW, Schwartz DA, et al. Stamford: Appleton and Lange; 1997:897\u2013903."},{"key":"79_CR29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-199705000-00003","volume":"76","author":"Durand D Vital","year":"1997","unstructured":"Vital Durand D, Lecomte C, Cath\u00e9bras P, et al.: Whipple disease: clinical review of 52 cases. Medicine 1997, 76:170\u2013184.","journal-title":"Medicine"},{"key":"79_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/qjmed\/90.12.765","volume":"90","author":"SA Misbah","year":"1997","unstructured":"Misbah SA, Ozols B, Franks A, Mapstone N: Whipple\u2019s disease without malabsorption:new atypical features. Q J Med. 1997, 90:765\u2013772. The only case of macrophagic myositis reported to a Whipple\u2019s disease, without bacterial detection from jejunal biopsies. The inconstant reliability of Tropheryma whippelii PCR-based detection and the negativity of digestive investigations, led to a cautious interpretation of these results.","journal-title":"Q J Med."},{"key":"79_CR31","first-page":"776","volume":"121","author":"DA Schwartz","year":"1997","unstructured":"Schwartz DA: Emerging and reemerging infections: progress and challenges in the subspecialty of infectious disease pathology. Arch Pathol Lab Med 1997, 121:776\u2013784.","journal-title":"Arch Pathol Lab Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0079-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-000-0079-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0079-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T05:01:15Z","timestamp":1683867675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-000-0079-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s11926-000-0079-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}